AXA (CSP) Q4 2025 (Media) earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 (Media) earnings summary
17 Apr, 2026Executive summary
Achieved record financial results in FY25, with revenues of €116 billion (+6%), underlying earnings of €8.4 billion (+6%), and underlying EPS of €3.86 (+8%), driven by strong growth across all business lines and geographies.
Net income rose 26% to €9.8 billion, benefiting from higher underlying earnings and the gain from the AXA IM sale.
Solvency II ratio improved to 224%, reflecting robust capital generation and prudent reserve management.
Laying foundations for the next strategic plan with a focus on technology, AI, and capital allocation.
Financial highlights
Revenues/premiums grew 6% year-over-year to €116 billion; underlying earnings €8.4 billion (+6%); net income €9.8 billion (+26%).
Underlying EPS: €3.86 (+8%); underlying ROE: 16.0%.
Dividend proposed at €2.32 per share (+8%) and new annual share buyback program up to €1.25 billion.
Debt gearing at 22.3%.
Solvency II ratio: 224% (+9pts), expected to adjust to 215% in 2026 due to regulatory changes.
Outlook and guidance
Confident in achieving the high end of the 6–8% underlying EPS growth target for 2026.
Solvency II revision expected to add +17 points to the ratio in 2027.
Next strategic plan for 2027–2029 to be presented in September 2026.
Guidance maintained for underlying ROE between 14–16% and cumulative organic cash upstream >€21 billion for 2024–2026.
Latest events from AXA
- Record growth, strong capital, and robust outlook with top-end EPS guidance for 2026.CSP
Q4 20257 Apr 2026 - Strong growth, AI-driven efficiency, and disciplined capital management underpin a positive outlook.CSP
Morgan Stanley European Financials Conference 202617 Mar 2026 - Record growth, €2.15 dividend, digital innovation, and climate action drive strong results.CSP
AGM 20253 Feb 2026 - 7% revenue growth, €5.4bn AXA IM sale, and strong capital drive strategic progress.CSP
Q2 20242 Feb 2026 - Ambitious growth, disciplined capital management, and proactive market strategies drive strong results.CSP
29th Annual Financials CEO Conference20 Jan 2026 - 7% revenue growth and a 221% solvency ratio support strong EPS growth targets.CSP
Q3 202417 Jan 2026 - 8% revenue and EPS growth, record earnings, and strong capital returns with 216% solvency.CSP
Q4 20247 Jan 2026 - 7% revenue growth, strong capital, and key strategic moves marked the quarter.CSP
Q1 202525 Nov 2025 - Premiums and revenues up 7% to €89.4B; Solvency II ratio rises to 222%.CSP
Q3 20253 Nov 2025